Patricia L. Bank came to Pacific Growth Equities with over 10 years of sell-side research experience. Patti joined Pacific Growth from EHS Securities where she was Senior Vice President focusing on the specialty pharmaceutical sector. Previously, Patti held senior pharma analyst positions at Vector Securities International, Wheat First Butcher Singer, and Mabon Securities. Prior to her work on Wall Street, Patti worked at Wallace Laboratories/Carter-Wallace, Inc. Patti received her MBA in investment management from Drexel University and her BA in neurobiology and economics from Rutgers University.

David joins Pacific Growth Equities from A.G. Edwards & Sons where he was a Senior Research Analyst following Medical Supplies and Devices. Prior to A.G. Edwards, David was an Associate Research Analyst with Banc of America Securities where he also followed Medical Supplies and Devices. Before coming to work on Wall Street, David was a Senior Consultant with Defined Health, a business development and strategic consulting firm, providing recommendations to the firm's pharmaceutical and biotech client base on potential licensing opportunities as well as advising clients on strategic partnering decisions. David also completed his residency training in the field of family medicine at UCLA Medical Center. David received his MBA from Harvard University, his medical degree from the Robert Wood Johnson Medical School at the University of Medicine and Dentistry, New Jersey, and his BS from Duke University.

Yun joined Pacific Growth Equities from A.G. Edwards & Sons where he was a Vice President and Senior Research Analyst covering the enterprise application software sector. Previously, Yun worked for several Wall Street firms as a software analyst including ThinkEquity Partners, CIBC World Markets, ABN AMRO, and Donaldson, Lufkin & Jenrette. Prior to working on Wall Street, Yun was a Senior Consultant with Accenture in its supply-chain, SAP, and eCommerce practices. Yun received his MS in Biomedical Engineering from Northwestern University, his BS in Bioengineering from the University of California, Berkeley and his BA in Economics from the University of California, Santa Cruz.

Un K. Kwon-Casado joined Pacific Growth Equities from Infinium Securities in San Francisco where she was the Senior Research Analyst following the life sciences tools sector. Prior to focusing her research in the life sciences tools space, Un was the Associate Biotechnology Analyst for Infinium Capital in Toronto, Canada. Un received her Masters of Sciences in Molecular and Cellular Biology from the University of Toronto and her Bachelor of Science in Biochemistry from Queen's University.

Kimberly Lee joined Pacific Growth Equities as a biotech equity research associate in 2006. Kim began her career on Wall Street as a biotech equity research associate with Jefferies & Co. and Stephens Inc. and prior to that, was a practicing obstetrician and gynecologist. Kim received her DO from the Kirksville College of Osteopathic Medicine and her BS in Biological Sciences from Stanford University.

Liana came to Pacific Growth Equities from UBS Global Asset Management where she was director and portfolio manager of the UBS Global Biotech Funds for five years. Previously, Liana was with Bristol-Meyers Squibb where she was a manager in University and Government Licensing, External Science and Technology. Liana has also worked with Sloan-Kettering Cancer Institute in the office of Industrial Affairs and the National Cancer Institute in the Office of Technology Development. Liana received her BS in Entomology and her MS in Zoology and Biochemistry from Clemson University, her Ph.D. in Plant Pathology from the University of California, Davis and completed a postdoctoral research fellowship in cellular and molecular Physiology at the Yale School of Medicine.

Kaushik Roy joined Pacific Growth Equities from Neuberger Berman where he was a Technology Research Analyst for the Neuberger Berman Technology Fund. Previously, Kaushik was the Senior Enterprise Hardware Technology Analyst with Susquehanna Financial Group for three years. Kaushik also followed the enterprise hardware sector with First Albany and Robertson Stephens earlier in his career. Prior to working on Wall Street, Kaushik was with EMC Corporation as a Strategic Investment Manager and with John Deere Healthcare as a Systems Engineer. Kaushik received his MBA from Cornell University, his MS in Electrical and Computer Engineering from Louisiana State University and his BS in Electrical Engineering from the Bihar Institute of Technology.

Greg is a Research Analyst on the Healthcare Equity Research team and specializes in Biotechnology. He joined Pacific Growth in January 2000 from Isis Pharmaceuticals where he was the Associate Director of Business Development. Previous to that he was the Manager of Corporate Development for Procyon BioPharma, Inc., and with Helix Investments, Inc., a Toronto based venture capital firm. B.S., Medical Biophysics: Ph.D., Physiology, University of Western Ontario.

Tim joined Pacific Growth Equities in 2006 with almost 20 years of investment experience analyzing and investing in the biotechnology industry and currently serves on the Firm's Executive and Commitment Committees. Most recently, Tim was a Senior Partner with Atlas Ventures in its London office responsible for making biotechnology venture capital investments. Previously with Bear Stearns, Tim was a Senior Managing Director responsible for equity research of the global biotechnology and European healthcare sectors. He has also served as a Managing Director covering the biotechnology sector on both sides of the Atlantic with SG Cowen, UBS Securities and Hambrecht & Quist. Tim began his career as an investment advisor with Rothschild Asset Management focused on the biotechnology industry. Tim received his Ph.D. in Molecular Biology from Cambridge University and a BSc (Hons) in Biochemistry from Imperial College, London.

Derrick joined the Pacific Growth Equities research department in early 2000. Since 2002, Derrick has covered Enterprise Software, and in early 2006, broadened his universe to include Digital Media companies. Derrick received his BS/BA in Economics from the University of California, Davis. Derrick is a CFA Charterholder.